Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphine-6 beta-glucuronide induces potent immunomodulation.

K A Carrigan1, D T Lysle

  • 1Biological Psychology Program, Department of Psychology, Davie Hall, CB#3270, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3270, USA. kelly@isis.unc.edu

International Immunopharmacology
|May 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Inflammation·2001
Same author

Involvement of substance P and central opioid receptors in morphine modulation of the CHS response.

Journal of neuroimmunology·2001
Same author

Morphine modulation of the contact hypersensitivity response: characterization of immunological changes.

Clinical immunology (Orlando, Fla.)·2001
Same author

Naltrexone administration attenuates surgery-induced immune alterations in rats.

The Journal of surgical research·2000
Same author

Endomorphin-1 induces antinociception without immunomodulatory effects in the rat.

Psychopharmacology·2000
Same author

Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.

Brain, behavior, and immunity·2000
Same journal

Berbamine improves behavioral impairments in Huntington's disease mice models through inhibiting Src/AKT1/NFκB signaling pathway and attenuating Src-mediated mitophagy suppression.

International immunopharmacology·2026
Same journal

Macrophage autophagy in allergic diseases: Regulatory mechanisms, immune crosstalk, and therapeutic implications.

International immunopharmacology·2026
Same journal

ANXA11 recruits tumor-associated neutrophils to promote the progression of colorectal cancer.

International immunopharmacology·2026
Same journal

HO-1 alleviates lipopolysaccharide-induced acute lung injury in mice by downregulating TFE3 expression and nuclear translocation and suppressing Golgi stress response.

International immunopharmacology·2026
Same journal

Corrigendum to "Eicosapentaenoic acid attenuates hyperoxia-induced lung injury via p38 MAPK/NF-κB-mediated regulation of glycolytic reprogramming" [Int. Immunopharmacol. 168(Part 2) (2026) 115903].

International immunopharmacology·2026
Same journal

ENOX1 promotes gastric cancer progression via Snail2-mediated epithelial-mesenchymal transition and M2-type tumour-associated macrophages polarisation.

International immunopharmacology·2026
See all related articles

Morphine metabolite morphine-6 beta-glucuronide (M6G) provides potent pain relief and suppresses immune responses in rats. These effects, particularly on immune function, suggest central nervous system mediation.

Area of Science:

  • Pharmacology
  • Immunology
  • Neuroscience

Background:

  • Morphine's effects on immunity are known, but its metabolites' roles are less understood.
  • Morphine-6 beta-glucuronide (M6G) is a major active metabolite of morphine.
  • Investigating M6G's impact on immune status is crucial for understanding opioid pharmacology.

Purpose of the Study:

  • To investigate the immunomodulatory effects of M6G in rats.
  • To evaluate the antinociceptive (pain-relieving) properties of M6G.
  • To explore the potential central mediation of M6G's immunomodulatory actions.

Main Methods:

  • Rats received M6G or placebo via subcutaneous or intracerebroventricular routes.
  • Antinociception was assessed using the warm water tail-withdrawal test.

Related Experiment Videos

  • Immune parameters including natural killer cell activity, lymphocyte proliferation, and interferon-gamma production were measured.

    • Main Results:

    • M6G demonstrated potent and sustained antinociception.
    • M6G significantly decreased natural killer cell activity, lymphocyte proliferation, and interferon-gamma production.
    • Route of administration influenced the potency of M6G's immunomodulatory effects, suggesting central mediation.

    Conclusions:

    • M6G possesses significant antinociceptive and immunomodulatory properties in rats.
    • The findings highlight the potent immunomodulatory capacity of a morphine metabolite.
    • Central mechanisms likely mediate M6G's effects on the immune system.